A CBD Smoking Pilot Reduced Cigarette Counts Without Reducing Craving
A small smoking study summarized in the substance-use review found fewer cigarettes smoked during CBD treatment without a corresponding reduction in nicotine craving. Consumption and subjective urge supplied different outcomes.
The trial was short and small
The review describes a double-blind placebo-controlled pilot involving 24 smokers, with inhaled CBD used over seven days. Cigarette counts decreased with CBD, but craving did not. Anxiety showed only a slight, nonsignificant reduction. These distinctions should remain visible in a summary of the study.
A count is not a complete cessation outcome
Fewer cigarettes during one week can be a useful behavioral signal, but it does not establish sustained abstinence, a reduced probability of later relapse or recovery from nicotine dependence. It also does not show that the mechanism was reduced craving, since that measure did not improve in parallel.
The finding belongs to the tested product and schedule
The review’s account does not validate retail CBD oils, a general inhalation regimen or a personal dose. The small sample limits precision and the assessment of uncommon harms. The appropriate conclusion is a short-term consumption finding accompanied by null subjective outcomes. Keeping the cigarette count, craving measure, duration and comparator together avoids either overlooking the behavioral signal or enlarging it into proven long-term smoking-cessation efficacy.
Related analysis: the broader review findings and limitations.
Research cited
This analysis draws on the supplied review. Individual studies are discussed as summarized there: Navarrete and colleagues (2021). Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders.
